Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Mathematical and Physical Modeling Principles of Complex Biological Systems Read chapter Read first chapter

2019 | OriginalPaper | Chapter

The Tear Film: Pathological Conditions

Authors : Vikram Paranjpe, Anat Galor

Published in: Ocular Fluid Dynamics

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

This chapter first reviews the pathogenesis of dry eye (DE) and the pathological effects DE has on the properties and composition of the tear film, lacrimal and meibomian glands, and goblet cells. Next, the pathologic changes that occur with two DE related risk factors: aging and the use of glaucoma eye drops are discussed. Finally, the clinical consequences of tear film, lacrimal gland, meibomian gland, and goblet cell alterations, focusing on visual function, nerve modulation, quality of life, and economic burden, are explored.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
previous chapter The Tear Film: Anatomy and Physiology
next chapter Imaging Techniques for the Visualization and Evaluation of Tear Film Dynamics
Literature
1.
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). The ocular surface. 2007;5(2):75-92.
2.
Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78(3):409-416.CrossRef
3.
Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. The ocular surface. 2017;15(3):334-365.CrossRef
4.
Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Investigative ophthalmology & visual science. 2011;52(10):7725-7730.CrossRef
5.
Corrales RM, Villarreal A, Farley W, Stern ME, Li DQ, Pflugfelder SC. Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. Cornea. 2007;26(5):579-584.CrossRef
6.
Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147(2):198-205 e191.CrossRef
7.
Corrales RM, Stern ME, De Paiva CS, Welch J, Li DQ, Pflugfelder SC. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Investigative ophthalmology & visual science. 2006;47(8):3293-3302.CrossRef
8.
Wei Y, Asbell PA. The core mechanism of dry eye disease is inflammation. Eye Contact Lens. 2014;40(4):248-256.CrossRef
9.
Wei Y, Pinhas A, Liu Y, Epstein S, Wang J, Asbell P. Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands. Investigative ophthalmology & visual science. 2012;53(6):2845-2855.CrossRef
10.
Higuchi A, Kawakita T, Tsubota K. IL-6 induction in desiccated corneal epithelium in vitro and in vivo. Molecular vision. 2011;17:2400-2406.
11.
Bandamwar KL, Papas EB, Garrett Q. Fluorescein staining and physiological state of corneal epithelial cells. Contact lens & anterior eye: the journal of the British Contact Lens Association. 2014;37(3):213-223.CrossRef
12.
Burstein NL. The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc U K. 1985;104 (Pt 4):402-409.
13.
Butovich IA, Lu H, McMahon A, Eule JC. Toward an animal model of the human tear film: biochemical comparison of the mouse, canine, rabbit, and human meibomian lipidomes. Investigative ophthalmology & visual science. 2012;53(11):6881-6896.CrossRef
14.
Jester JV, Nicolaides N, Kiss-Palvolgyi I, Smith RE. Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Investigative ophthalmology & visual science. 1989;30(5):936-945.
15.
Jester JV, Potma E, Brown DJ. PPARgamma Regulates Mouse Meibocyte Differentiation and Lipid Synthesis. The ocular surface. 2016;14(4):484-494.CrossRef
16.
Jester JV, Rajagopalan S, Rodrigues M. Meibomian gland changes in the rhino (hrrhhrrh) mouse. Investigative ophthalmology & visual science. 1988;29(7):1190-1194.
17.
McMahon A, Lu H, Butovich IA. A Role for ELOVL4 in the Mouse Meibomian Gland and Sebocyte Cell Biology. Investigative ophthalmology & visual science. 2014;55(5):2832-2840.CrossRef
18.
Parfitt GJ, Brown DJ, Jester JV. Transcriptome analysis of aging mouse meibomian glands. Molecular vision. 2016;22:518-527.
19.
Redfern RL, Patel N, Hanlon S, et al. Toll-like receptor expression and activation in mice with experimental dry eye. Investigative ophthalmology & visual science. 2013;54(2):1554-1563.CrossRef
20.
Rios JD, Horikawa Y, Chen LL, et al. Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Experimental eye research. 2005;80(4):477-491.CrossRef
21.
Zheng X, Bian F, Ma P, et al. Induction of Th17 differentiation by corneal epithelial-derived cytokines. J Cell Physiol. 2010;222(1):95-102.CrossRef
22.
Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. International reviews of immunology. 2013;32(1):19-41.CrossRef
23.
Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjogren’s and non-Sjogren’s patients with dry eye. Investigative ophthalmology & visual science. 2002;43(8):2609-2614.
24.
De Saint Jean M, Brignole F, Feldmann G, Goguel A, Baudouin C. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells. Investigative ophthalmology & visual science. 1999;40(10):2199-2212.
25.
Tiffany JM. Tears in health and disease. Eye (London, England). 2003;17(8):923-926.CrossRef
26.
Tiffany JM. The normal tear film. Developments in ophthalmology. 2008;41:1-20.
27.
Farris RL. Tear osmolarity--a new gold standard? Advances in experimental medicine and biology. 1994;350:495-503.
28.
Gilbard JP, Farris RL, Santamaria J, 2nd. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Archives of ophthalmology (Chicago, Ill: 1960). 1978;96(4):677-681.CrossRef
29.
Norn MS. Dead, degenerate, and living cells in conjunctival fluid and mucous thread. Acta Ophthalmol (Copenh). 1969;47(5):1102-1115.CrossRef
30.
Mengher LS, Bron AJ, Tonge SR, Gilbert DJ. Effect of fluorescein instillation on the pre-corneal tear film stability. Current eye research. 1985;4(1):9-12.CrossRef
31.
Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17(1):38-56.CrossRef
32.
Ohashi Y, Dogru M, Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta. 2006;369(1):17-28.CrossRef
33.
Walter SD, Gronert K, McClellan AL, Levitt RC, Sarantopoulos KD, Galor A. omega-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye. Investigative ophthalmology & visual science. 2016;57(6):2472-2478.
34.
Cortina MS, He J, Li N, Bazan NG, Bazan HE. Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Investigative ophthalmology & visual science. 2010;51(2):804-810.CrossRef
35.
Cortina MS, He J, Russ T, Bazan NG, Bazan HE. Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery. Investigative ophthalmology & visual science. 2013;54(6):4109-4116.CrossRef
36.
Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol. 2011;186(7):4455-4466.CrossRef
37.
Esquenazi S, Bazan HE, Bui V, He J, Kim DB, Bazan NG. Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Investigative ophthalmology & visual science. 2005;46(9):3121-3127.CrossRef
38.
Harauma A, Saito J, Watanabe Y, Moriguchi T. Potential for daily supplementation of n-3 fatty acids to reverse symptoms of dry eye in mice. Prostaglandins Leukot Essent Fatty Acids. 2014;90(6):207-213.CrossRef
39.
Kangari H, Eftekhari MH, Sardari S, et al. Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology. 2013;120(11):2191-2196.CrossRef
40.
Kawakita T, Kawabata F, Tsuji T, Kawashima M, Shimmura S, Tsubota K. Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial. Biomed Res. 2013;34(5):215-220.CrossRef
41.
Zoukhri D. Effect of inflammation on lacrimal gland function. Experimental eye research. 2006;82(5):885-898.CrossRef
42.
Manganelli P, Fietta P. Apoptosis and Sjogren syndrome. Semin Arthritis Rheum. 2003;33(1):49-65.CrossRef
43.
Mariette X. [Pathophysiology of Sjogren’s syndrome]. Ann Med Interne (Paris). 2003;154(3):157-168.
44.
Tapinos NI, Polihronis M, Tzioufas AG, Skopouli FN. Immunopathology of Sjogren’s syndrome. Ann Med Interne (Paris). 1998;149(1):17-24.
45.
Sullivan DA. Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. The ocular surface. 2004;2(2):92-123.MathSciNetCrossRef
46.
Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren’s syndrome androgen-deficient? The Journal of rheumatology. 2003;30(11):2413-2419.
47.
Sullivan DA, Krenzer KL, Sullivan BD, Tolls DB, Toda I, Dana MR. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? Investigative ophthalmology & visual science. 1999;40(6):1261-1265.
48.
Xiao B, Wang Y, Reinach PS, et al. Dynamic ocular surface and lacrimal gland changes induced in experimental murine dry eye. PloS one. 2015;10(1):e0115333.CrossRef
49.
McCulley JP, Shine WE. Meibomian gland function and the tear lipid layer. The ocular surface. 2003;1(3):97-106.CrossRef
50.
Nicolaides N, Santos EC, Smith RE, Jester JV. Meibomian gland dysfunction. III. Meibomian gland lipids. Investigative ophthalmology & visual science. 1989;30(5):946-951.
51.
Lam SM, Tong L, Yong SS, et al. Meibum lipid composition in Asians with dry eye disease. PloS one. 2011;6(10):e24339.CrossRef
52.
Joffre C, Souchier M, Gregoire S, et al. Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous-deficient dry eye. The British journal of ophthalmology. 2008;92(1):116-119.CrossRef
53.
Foulks GN. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol. 2007;52(4):369-374.CrossRef
54.
Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. The British journal of ophthalmology. 2016;100(3):300-306.CrossRef
55.
Hwang HS, Parfitt GJ, Brown DJ, Jester JV. Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD). Experimental eye research. 2017.CrossRef
56.
Jester JV, Parfitt GJ, Brown DJ. Meibomian gland dysfunction: hyperkeratinization or atrophy? BMC ophthalmology. 2015;15 Suppl 1:156.
57.
Rosen ED, Sarraf P, Troy AE, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999;4(4):611-617.
58.
Rosen ED, Spiegelman BM. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. The Journal of biological chemistry. 2001;276(41):37731-37734.CrossRef
59.
Petroll WM, Jester JV, Bean JJ, Cavanagh HD. Myofibroblast transformation of cat corneal endothelium by transforming growth factor-beta1, -beta2, and -beta3. Investigative ophthalmology & visual science. 1998;39(11):2018-2032.
60.
Argueso P, Gipson IK. Epithelial mucins of the ocular surface: structure, biosynthesis and function. Experimental eye research. 2001;73(3):281-289.CrossRef
61.
Gipson IK. Distribution of mucins at the ocular surface. Experimental eye research. 2004;78(3):379-388.CrossRef
62.
Mantelli F, Argueso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol. 2008;8(5):477-483.CrossRef
63.
Stephens DN, McNamara NA. Altered Mucin and Glycoprotein Expression in Dry Eye Disease. Optom Vis Sci. 2015;92(9):931-938.CrossRef
64.
Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Experimental eye research. 2013;117:28-38.CrossRef
65.
Shimazaki-Den S, Dogru M, Higa K, Shimazaki J. Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea. 2013;32(9):1211-1218.CrossRef
66.
Tiffany JM, Winter N, Bliss G. Tear film stability and tear surface tension. Current eye research. 1989;8(5):507-515.CrossRef
67.
Van Haeringen NJ. Aging and the lacrimal system. The British journal of ophthalmology. 1997;81(10):824-826.CrossRef
68.
Xu KP, Tsubota K. Correlation of tear clearance rate and fluorophotometric assessment of tear turnover. The British journal of ophthalmology. 1995;79(11):1042-1045.CrossRef
69.
Nava A, Barton K, Monroy DC, Pflugfelder SC. The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea. 1997;16(4):430-438.CrossRef
70.
van Best JA, Benitez del Castillo JM, Coulangeon LM. Measurement of basal tear turnover using a standardized protocol. European concerted action on ocular fluorometry. Graefes Arch Clin Exp Ophthalmol. 1995;233(1):1-7.
71.
Furukawa RE, Polse KA. Changes in tear flow accompanying aging. Am J Optom Physiol Opt. 1978;55(2):69-74.CrossRef
72.
Hirase K, Shimizu A, Yokoi N, Nishida K, Kinoshita S. [Age-related alteration of tear dynamics in normal volunteers]. Nippon Ganka Gakkai zasshi. 1994;98(6):575-578.
73.
Hagele JE, Guzek JP, Shavlik GW. Lacrimal testing. Age as a factor in Jones testing. Ophthalmology. 1994;101(3):612-617.CrossRef
74.
McGill JI, Liakos GM, Goulding N, Seal DV. Normal tear protein profiles and age-related changes. The British journal of ophthalmology. 1984;68(5):316-320.CrossRef
75.
Mathers WD, Lane JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea. 1996;15(3):229-234.CrossRef
76.
Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology. 1995;102(4):678-686.CrossRef
77.
Ueno H, Ariji E, Izumi M, Uetani M, Hayashi K, Nakamura T. MR imaging of the lacrimal gland. Age-related and gender-dependent changes in size and structure. Acta Radiol. 1996;37(5):714-719.CrossRef
78.
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). The ocular surface. 2007;5(2):108-152.
79.
Bromberg BB, Cripps MM, Welch MH. Sympathomimetic protein secretion by young and aged lacrimal gland. Current eye research. 1986;5(3):217-223.CrossRef
80.
Bromberg BB, Welch MH. Lacrimal protein secretion: comparison of young and old rats. Experimental eye research. 1985;40(2):313-320.CrossRef
81.
Draper CE, Adeghate E, Lawrence PA, Pallot DJ, Garner A, Singh J. Age-related changes in morphology and secretory responses of male rat lacrimal gland. J Auton Nerv Syst. 1998;69(2-3):173-183.CrossRef
82.
Jester BE, Nien CJ, Winkler M, Brown DJ, Jester JV. Volumetric reconstruction of the mouse meibomian gland using high-resolution nonlinear optical imaging. Anat Rec (Hoboken). 2011;294(2):185-192.CrossRef
83.
Nien CJ, Paugh JR, Massei S, Wahlert AJ, Kao WW, Jester JV. Age-related changes in the meibomian gland. Experimental eye research. 2009;89(6):1021-1027.CrossRef
84.
Borchman D, Foulks GN, Yappert MC, Milliner SE. Changes in human meibum lipid composition with age using nuclear magnetic resonance spectroscopy. Investigative ophthalmology & visual science. 2012;53(1):475-482.CrossRef
85.
Marquardt R, Wenz FH. [Histological studies of goblet cell counts in human conjunctiva (author’s transl)]. Klin Monbl Augenheilkd. 1979;175(5):692-696.
86.
Kessing SV. Mucous gland system of the conjunctiva. A quantitative normal anatomical study. Acta Ophthalmol (Copenh). 1968:Suppl 95:91+.
87.
Abdel-Khalek LM, Williamson J, Lee WR. Morphological changes in the human conjunctival epithelium. I. In the normal elderly population. The British journal of ophthalmology. 1978;62(11):792-799.CrossRef
88.
Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312-334.CrossRef
89.
Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. The British journal of ophthalmology. 1975;59(11):667-669.CrossRef
90.
Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res. 2000;32(1):3-8.CrossRef
91.
Yalvac IS, Gedikoglu G, Karagoz Y, et al. Effects of antiglaucoma drugs on ocular surface. Acta Ophthalmol Scand. 1995;73(3):246-248.CrossRef
92.
Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008;86(7):716-726.CrossRef
93.
Servat JJ, Bernardino CR. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging. 2011;28(4):267-282.CrossRef
94.
Kashkouli MB, Pakdel F, Hashemi M, et al. Comparing anatomical pattern of topical anti-glaucoma medications associated lacrimal obstruction with a control group. Orbit. 2010;29(2):65-69.CrossRef
95.
Kashkouli MB, Rezaee R, Nilforoushan N, Salimi S, Foroutan A, Naseripour M. Topical antiglaucoma medications and lacrimal drainage system obstruction. Ophthal Plast Reconstr Surg. 2008;24(3):172-175.CrossRef
96.
Nuzzi R, Finazzo C, Cerruti A. Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response. Int Ophthalmol. 1998;22(1):31-35.
97.
Mocan MC, Uzunosmanoglu E, Kocabeyoglu S, Karakaya J, Irkec M. The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction. J Glaucoma. 2016;25(9):770-774.CrossRef
98.
Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, Karakaya J, Irkec M. Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications. Cornea. 2016;35(8):1112-1116.CrossRef
99.
Arita R, Itoh K, Maeda S, et al. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands. Cornea. 2012;31(11):1229-1234.CrossRef
100.
Derous D, de Keizer RJ, de Wolff-Rouendaal D, Soudijn W. Conjunctival keratinisation, an abnormal reaction to an ocular beta-blocker. Acta Ophthalmol (Copenh). 1989;67(3):333-338.CrossRef
101.
Herreras JM, Pastor JC, Calonge M, Asensio VM. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1992;99(7):1082-1088.CrossRef
102.
Arici MK, Arici DS, Topalkara A, Guler C. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exp Ophthalmol. 2000;28(2):113-117.CrossRef
103.
Tseng SC, Hirst LW, Maumenee AE, Kenyon KR, Sun TT, Green WR. Possible mechanisms for the loss of goblet cells in mucin-deficient disorders. Ophthalmology. 1984;91(6):545-552.CrossRef
104.
Takahashi N. A new method evaluating quantitative time-dependent cytotoxicity of ophthalmic solutions in cell culture. Beta-adrenergic blocking agents. Graefes Arch Clin Exp Ophthalmol. 1983;220(6):264-267.CrossRef
105.
Tutt R, Bradley A, Begley C, Thibos LN. Optical and visual impact of tear break-up in human eyes. Investigative ophthalmology & visual science. 2000;41(13):4117-4123.
106.
Lee SH, Tseng SC. Rose bengal staining and cytologic characteristics associated with lipid tear deficiency. Am J Ophthalmol. 1997;124(6):736-750.CrossRef
107.
Bjerrum KB. Test and symptoms in keratoconjunctivitis sicca and their correlation. Acta Ophthalmol Scand. 1996;74(5):436-441.CrossRef
108.
Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjogren’s syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren’s syndrome. Ann Rheum Dis. 1994;53(10):637-647.CrossRef
109.
Narayanan S, Redfern RL, Miller WL, Nichols KK, McDermott AM. Dry eye disease and microbial keratitis: is there a connection? The ocular surface. 2013;11(2):75-92.CrossRef
110.
Kwong MS, Evans DJ, Ni M, Cowell BA, Fleiszig SM. Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model. Infect Immun. 2007;75(5):2325-2332.CrossRef
111.
Jhanji V, Constantinou M, Taylor HR, Vajpayee RB. Microbiological and clinical profiles of patients with microbial keratitis residing in nursing homes. The British journal of ophthalmology. 2009;93(12):1639-1642.CrossRef
112.
Boiko EV, Chernysh VF, Pozniak AL, Ageev VS. [To the role of Chlamydia infection in the development of dry eye]. Vestn Oftalmol. 2008;124(4):16-19.
113.
Krasny J, Hruba D, Netukova M, Kodat V, Tomasova BJ. [Chlamydia pneumoniae in the etiology of the keratoconjunctivitis sicca in adult patients (a pilot study)]. Cesk Slov Oftalmol. 2009;65(3):102-106.
114.
Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. The British journal of ophthalmology. 2003;87(7):834-838.CrossRef
115.
Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113(1):109-116.CrossRef
116.
Albietz JM, Lenton LM. Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease. Cornea. 2006;25(9):1012-1019.CrossRef
117.
Graham JE, Moore JE, Jiru X, et al. Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Investigative ophthalmology & visual science. 2007;48(12):5616-5623.CrossRef
118.
Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. The British journal of ophthalmology. 1984;68(8):524-528.CrossRef
119.
Seal DV, McGill JI, Mackie IA, Liakos GM, Jacobs P, Goulding NJ. Bacteriology and tear protein profiles of the dry eye. The British journal of ophthalmology. 1986;70(2):122-125.CrossRef
120.
Sharma S. Diagnosis of external ocular infections: microbiological processing and interpretation. The British journal of ophthalmology. 2000;84(2):229.CrossRef
121.
Ta CN, Chang RT, Singh K, et al. Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology. 2003;110(10):1946-1951.CrossRef
122.
Cuello OH, Caorlin MJ, Reviglio VE, et al. Rhodococcus globerulus keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2002;28(12):2235-2237.CrossRef
123.
Fleiszig SM, Evans DJ. Contact lens infections: can they ever be eradicated? Eye Contact Lens. 2003;29(1 Suppl):S67-71; discussion S83-64, S192-194.
124.
Shine WE, Silvany R, McCulley JP. Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Investigative ophthalmology & visual science. 1993;34(7):2291-2296.
125.
Redfern RL, McDermott AM. Toll-like receptors in ocular surface disease. Experimental eye research. 2010;90(6):679-687.CrossRef
126.
Pearlman E, Johnson A, Adhikary G, et al. Toll-like receptors at the ocular surface. The ocular surface. 2008;6(3):108-116.CrossRef
127.
Lee HS, Hattori T, Park EY, Stevenson W, Chauhan SK, Dana R. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Investigative ophthalmology & visual science. 2012;53(9):5632-5640.CrossRef
128.
Lan J, Willcox MD, Jackson GD. Effect of tear-specific immunoglobulin A on the adhesion of Pseudomonas aeruginosa I to contact lenses. Aust N Z J Ophthalmol. 1999;27(3-4):218-220.CrossRef
129.
Mantis NJ, Rol N, Corthesy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4(6):603-611.CrossRef
130.
Caffery B, Joyce E, Boone A, et al. Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye. Optom Vis Sci. 2008;85(8):661-667.CrossRef
131.
Buckland AG, Wilton DC. The antibacterial properties of secreted phospholipases A(2). Biochim Biophys Acta. 2000;1488(1-2):71-82.CrossRef
132.
Aho VV, Nevalainen TJ, Saari KM. Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis sicca. Graefes Arch Clin Exp Ophthalmol. 2002;240(7):521-523.CrossRef
133.
Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Investigative ophthalmology & visual science. 2002;43(4):1004-1011.
134.
Govindarajan B, Gipson IK. Membrane-tethered mucins have multiple functions on the ocular surface. Experimental eye research. 2010;90(6):655-663.CrossRef
135.
136.
Huang LC, Reins RY, Gallo RL, McDermott AM. Cathelicidin-deficient (Cnlp -/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Investigative ophthalmology & visual science. 2007;48(10):4498-4508.CrossRef
137.
Mantelli F, Massaro-Giordano M, Macchi I, Lambiase A, Bonini S. The cellular mechanisms of dry eye: from pathogenesis to treatment. J Cell Physiol. 2013;228(12):2253-2256.CrossRef
138.
Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol. 1993;92(1 Pt 1):95-104.
139.
Kovacs I, Ludany A, Koszegi T, et al. Substance P released from sensory nerve endings influences tear secretion and goblet cell function in the rat. Neuropeptides. 2005;39(4):395-402.CrossRef
140.
Mantelli F, Micera A, Sacchetti M, Bonini S. Neurogenic inflammation of the ocular surface. Curr Opin Allergy Clin Immunol. 2010;10(5):498-504.CrossRef
141.
Beuerman RW, Stern ME. Neurogenic inflammation: a first line of defense for the ocular surface. The ocular surface. 2005;3(4 Suppl):S203-206.CrossRef
142.
Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2008;123(3):398-410.CrossRef
143.
Tuisku IS, Konttinen YT, Konttinen LM, Tervo TM. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjogren’s syndrome. Experimental eye research. 2008;86(6):879-885.CrossRef
144.
Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143(3):409-415.CrossRef
145.
Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Investigative ophthalmology & visual science. 2005;46(1):46-50.CrossRef
146.
Nelson JD, Helms H, Fiscella R, Southwell Y, Hirsch JD. A new look at dry eye disease and its treatment. Advances in therapy. 2000;17(2):84-93.CrossRef
147.
Hirsch JD. Considerations in the pharmacoeconomics of glaucoma. Manag Care. 2002;11(11 Suppl):32-37.
148.
Reddy P, Grad O, Rajagopalan K. The economic burden of dry eye: a conceptual framework and preliminary assessment. Cornea. 2004;23(8):751-761.CrossRef
149.
Kozma CMH, J.D.; Wojcik, A.R.;. Economic and quality of life impact of dry eye symptoms. Poster at the Annual Meeting of the Association for Research in Vision and Ophthalmology; April 30-May 5, 2000, 2000; Fort Lauderdale, Florida.
150.
Lee JTT, C.W. Development of an economic model to assess costs and outcomes associated with dry eye disease. Poster at the 2000 Spring Practice and Research Forum of the American College of Clinical Pharmacy; April 2-5, 2000, 2000; Monterey, California.
151.
Smeeding JEM, C.; Walt, J.G. Dry-eye increases in health care and utilization and expenditures. Poster at the Sixth Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 20-23, 2001, 2001; Arlington, Virginia.
152.
Pflugfelder SC. Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care. 2008;14(3 Suppl):S102-106.
153.
Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107(4):631-639.CrossRef
154.
Cross WD, Lay LF, Jr., Walt JG, Kozma CM. Clinical and economic implications of topical cyclosporin A for the treatment of dry eye. Manag Care Interface. 2002;15(9):44-49.
Metadata
Title
The Tear Film: Pathological Conditions
Authors
Vikram Paranjpe
Anat Galor
Copyright Year
2019
Book
Ocular Fluid Dynamics

Print ISBN: 978-3-030-25885-6

Electronic ISBN: 978-3-030-25886-3

Copyright Year: 2019

DOI
https://doi.org/10.1007/978-3-030-25886-3_15

Premium Partners

    Image Credits